{"id":64909,"date":"2022-12-12T18:47:55","date_gmt":"2022-12-12T16:47:55","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=64909"},"modified":"2023-10-09T13:05:56","modified_gmt":"2023-10-09T13:05:56","slug":"dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/","title":{"rendered":"Dermofarmacia y oncolog\u00eda. Actuaciones desde la farmacia comunitaria"},"content":{"rendered":"<p>El pasado 23 de noviembre, el <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> realiz\u00f3 una nueva formaci\u00f3n sobre \u201c<strong>La dermofarmacia y la oncolog\u00eda<\/strong>\u201d, con la colaboraci\u00f3n de <a href=\"https:\/\/www.laroche-posay.es\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>La Roche-Posay<\/strong><\/a>. La jornada fue moderada por la vocal de Dermofarmacia y Productos Sanitarios del COFB, <strong>Marta Alcalde <\/strong>y dio a conocer cu\u00e1les son las <strong>cuidados dermocosm\u00e9ticos<\/strong> y las<strong> recomendaciones de actuaci\u00f3n<\/strong>, saber cu\u00e1l es el<strong>impacto psicol\u00f3gico <\/strong>que genera el <strong>diagn\u00f3stico del c\u00e1ncer<\/strong> y cu\u00e1les <strong>habilidades comunicativas<\/strong> se recomiendan seguir en el<strong>atenci\u00f3n dermofarmac\u00e9utica<\/strong>. Asimismo, la jornada cont\u00f3 con un <strong>taller pr\u00e1ctico de maquillaje terap\u00e9utico<\/strong> corrector, uno <strong>caso pr\u00e1ctico real<\/strong> y uno <strong>di\u00e1logo entre profesionales<\/strong> de distintos \u00e1mbitos. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\" target=\"_blank\" rel=\"noopener\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\" alt=\"\" class=\"wp-image-68983\" title=\"El dermat\u00f3logo, Oriol Corral, en un momento de su exposici\u00f3n.\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-300x150.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-768x384.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-18x9.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">La vocal de Dermofarmacia y productos Sanitarios del COFB, Marta Alcalde, moder\u00f3 jornada. <\/figcaption><\/figure>\n\n\n\n<p>Uno de los <strong>objetivos<\/strong> principales de la actividad formativa, seg\u00fan <strong>Alcalde<\/strong>, fue que \u201c<strong>el farmac\u00e9utico est\u00e9 cada vez m\u00e1s formado <\/strong>en este sentido, ya que <strong>son terapias que mayoritariamente se realizan en el \u00e1mbito hospitalario<\/strong> y <strong>su funcionamiento no es muy conocido por la farmacia comunitaria<\/strong>\u201d. Desde este \u00e1mbito la vocal destac\u00f3 que &quot;un punto importante en este tipo de paciente es el abordaje y el acompa\u00f1amiento emocional&quot;.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Datos actuales sobre el c\u00e1ncer<\/strong><\/h2>\n\n\n\n<p>El dermat\u00f3logo en la cl\u00ednica iDermic y en el Hospital Universitario M\u00fatua de Terrassa, el <strong>Dr. Oriol Corral<\/strong>, inici\u00f3 la formaci\u00f3n explicando qu\u00e9 es el c\u00e1ncer y haciendo un repaso de las <strong>datos actuales del c\u00e1ncer<\/strong> a nivel estatal. Seg\u00fan el<strong><a href=\"https:\/\/seom.org\/images\/LAS_CIFRAS_DEL_CANCER_EN_ESPANA_2022.pdf\">informe<\/a><\/strong> de 2022 publicado por <strong>la Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM)<\/strong> se estima que <strong>se diagnosticar\u00e1n 280.100 casos anuales<\/strong> y que la <strong>incidencia aumentar\u00e1 <\/strong>los pr\u00f3ximos a\u00f1os, siendo los <strong>c\u00e1nceres m\u00e1s diagnosticados<\/strong>: el de colon y recto, mama, pulm\u00f3n, pr\u00f3stata y el de vejiga urinaria. En cuanto al aumento de la incidencia de casos, seg\u00fan el informe de la SEOM, se debe al aumento poblacional, al envejecimiento de la poblaci\u00f3n, la exposici\u00f3n de los factores de riesgo y en algunos tipos de c\u00e1ncer por el aumento de la detecci\u00f3n precoz.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_11.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_11.jpg\" alt=\"El dermat\u00f2leg, Oriol Corral, en un moment de la seva exposici\u00f3.\" class=\"wp-image-64948\" title=\"El dermat\u00f3logo, Oriol Corral, en un momento de su exposici\u00f3n.\"\/><\/a><figcaption class=\"wp-element-caption\">El dermat\u00f3logo, Oriol Corral, en un momento de su exposici\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p>El doctor Corral detall\u00f3 las distintas <strong>terapias actuales existentes para tratar el c\u00e1ncer<\/strong> y los efectos que producen en la piel, terapias como: <strong>la cirug\u00eda, la radioterapia, la quimioterapia, la hormonoterapia, las terapias dirigidas y la inmunoterapia<\/strong>. Muchos de estos tratamientos pueden generar <strong>efectos adversos sobre la piel<\/strong> y que la imagen se vea afectada.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El impacto psicol\u00f3gico en las personas con c\u00e1ncer<\/strong><\/h2>\n\n\n\n<p><strong>El c\u00e1ncer<\/strong>, en muchos casos, <strong>genera un impacto psicol\u00f3gico<\/strong> tanto en el paciente diagnosticado como en su entorno, familiares y cuidadores.<strong> <\/strong>La psicoonc\u00f3loga especialista en ansiedad y estr\u00e9s y responsable del Servicio de Psicooncolog\u00eda del Hospital MD Anderson C\u00e1ncer Center de Madrid, <strong>Marta de la Fuente<\/strong>, hizo un repaso de las fases del<strong>impacto psicol\u00f3gico <\/strong>en el <strong>paciente diagnosticado de c\u00e1ncer<\/strong>. Tambi\u00e9n explic\u00f3 <strong>qu\u00e9 hacer y c\u00f3mo gestionar la afectaci\u00f3n emocional del paciente con c\u00e1ncer que acude a la farmacia<\/strong> y ofreci\u00f3 <strong>peque\u00f1as pautas para dirigirse a los pacientes oncol\u00f3gicos con empat\u00eda<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_4-scaled.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_4-1024x576.jpg\" alt=\"La psic\u00f2loga sanit\u00e0ria, Marta de la Fuente, durant la seva intervenci\u00f3.\" class=\"wp-image-64953\" title=\"La psic\u00f3loga sanitaria, Marta de la Fuente, durante su intervenci\u00f3n.\"\/><\/a><figcaption class=\"wp-element-caption\">La psic\u00f3loga sanitaria, Marta de la Fuente, durante su intervenci\u00f3n.<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Cuidados dermocosm\u00e9ticos como complemento terap\u00e9utico<\/strong><\/h2>\n\n\n\n<p>En cuanto a las <strong>cuidados dermocosm\u00e9ticos<\/strong> en el paciente oncol\u00f3gico, el diplomado en tecnolog\u00eda cardiopulmonar y responsable del Departamento de Oncolog\u00eda de La Roche Posay, <strong>Jes\u00fas P\u00e9rez Fierro<\/strong>, expuso el porqu\u00e9 son importantes los cuidados, qu\u00e9 ingredientes cosm\u00e9ticos se aconseja utilizar y cu\u00e1les son las recomendaciones de actuaci\u00f3n en dermocosm\u00e9tica. \u201c<strong>La higiene, la hidrataci\u00f3n, la cicatrizaci\u00f3n y la protecci\u00f3n solar<\/strong> son algunas de las<strong> cuidados dermocosm\u00e9ticos <\/strong>que se pueden ofrecer como complemento terap\u00e9utico\u201d, detall\u00f3 el profesional. Durante la formaci\u00f3n, P\u00e9rez Fierro remarc\u00f3 <strong>la importancia de tener varios productos, testados en pacientes oncol\u00f3gicos, para poder dar un buen consejo<\/strong>, en lo que respecta al cuidado de la piel, en cada situaci\u00f3n. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_2.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_2-1024x546.jpg\" alt=\"Jes\u00fas P\u00e9rez Fierro en la seva exposici\u00f3 sobre les cures dermocosm\u00e8tiques i el pacient oncol\u00f2gic.\" class=\"wp-image-64950\" title=\"Jes\u00fas P\u00e9rez Fierro en su exposici\u00f3n sobre los cuidados dermocosm\u00e9ticos y el paciente oncol\u00f3gico.\"\/><\/a><figcaption class=\"wp-element-caption\">Jes\u00fas P\u00e9rez Fierro en su exposici\u00f3n sobre los cuidados dermocosm\u00e9ticos y el paciente oncol\u00f3gico.<\/figcaption><\/figure>\n\n\n\n<p>Durante la jornada de formaci\u00f3n, se realiz\u00f3 un <strong>taller pr\u00e1ctico de maquillaje terap\u00e9utico<\/strong> con la maquilladora profesional especializada en maquillaje terap\u00e9utico corrector en paciente oncol\u00f3gico y colaboradora del Departamento de Oncolog\u00eda de los Laboratorios La Roche-Posay, <strong>Bego\u00f1a G\u00f3mez<\/strong>. La profesional <strong>asesor\u00f3 sobre qu\u00e9 tipos de maquillaje, modelos y caracter\u00edsticas t\u00e9cnicas son recomendables <\/strong>para las personas con c\u00e1ncer.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/12\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_8-scaled.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/12\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_8-1024x576.jpg\" alt=\"La maquilladora professional, Bego\u00f1a G\u00f3mez, impartint el taller pr\u00e0ctic de maquillatge terap\u00e8utic.\" class=\"wp-image-65467\" title=\"La maquilladora profesional, Bego\u00f1a G\u00f3mez, impartiendo el taller pr\u00e1ctico de maquillaje terap\u00e9utico.\"\/><\/a><figcaption class=\"wp-element-caption\">La maquilladora profesional, Bego\u00f1a G\u00f3mez, impartiendo el taller pr\u00e1ctico de maquillaje terap\u00e9utico.<\/figcaption><\/figure>\n\n\n<div class=\"destacat-blog\">\n\n\n<h2 class=\"wp-block-heading\"><strong>El paciente oncol\u00f3gico en la oficina de farmacia<\/strong> <\/h2>\n\n\n\n<p>Actualmente, cada vez hay m\u00e1s <strong>pacientes con enfermedades oncol\u00f3gicas<\/strong> que llegan a la <strong>farmacia <\/strong>pidiendo<strong> consejo<\/strong> por alg\u00fan problema en la piel en relaci\u00f3n con los <strong>tratamientos<\/strong>. El licenciado en farmacia y responsable del Departamento de oncolog\u00eda de La Roche-Posay, <strong>David Gardu\u00f1o<\/strong>, en su ponencia, habl\u00f3 a grandes rasgos del funcionamiento de cada uno de los tratamientos, para que el farmac\u00e9utico comunitario pueda tener identificados sobre cu\u00e1les<strong> efectos secundarios<\/strong> debe informar al paciente, en funci\u00f3n de cu\u00e1l sea el<strong> tipos de terapia<\/strong> que reciba.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_6-1.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_6-1-1024x667.jpg\" alt=\"David Gardu\u00f1o en la seva intervenci\u00f3 sobre com l\u2019atenci\u00f3 del pacient oncol\u00f2gic pot millorar el model d\u2019atenci\u00f3 farmac\u00e8utica. \" class=\"wp-image-64954\" title=\" David Gardu\u00f1o en su intervenci\u00f3n sobre c\u00f3mo la atenci\u00f3n del paciente oncol\u00f3gico puede mejorar el modelo de atenci\u00f3n farmac\u00e9utica. \"\/><\/a><figcaption class=\"wp-element-caption\"> David Gardu\u00f1o en su intervenci\u00f3n sobre c\u00f3mo la atenci\u00f3n del paciente oncol\u00f3gico puede mejorar el modelo de atenci\u00f3n farmac\u00e9utica. <\/figcaption><\/figure>\n\n\n\n<p><strong>Gardu\u00f1o <\/strong>recalc\u00f3 el hecho de que el<strong>atenci\u00f3n del paciente oncol\u00f3gico puede mejorar<\/strong> el modelo de atenci\u00f3n farmac\u00e9utica, haciendo de la farmacia comunitaria:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Un espacio de atenci\u00f3n.<\/li>\n\n\n\n<li>De seguimiento del paciente oncol\u00f3gico.<\/li>\n\n\n\n<li>De comunicaci\u00f3n.<\/li>\n\n\n\n<li>De creaci\u00f3n del servicio\/categor\u00eda de cuidados especiales.<\/li>\n<\/ul>\n\n\n\n<p>Para ilustrar el rol del farmac\u00e9utico comunitario en el consejo y atenci\u00f3n en el paciente oncol\u00f3gico la farmac\u00e9utica, <strong>Silvia Jim\u00e9nez<\/strong>, expuso un caso pr\u00e1ctico real.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_5.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/11\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_5-1024x593.jpg\" alt=\"La farmac\u00e8utica, S\u00edlvia Jim\u00e9nez, comentant un cas pr\u00e0ctic. \" class=\"wp-image-64957\" title=\"La farmac\u00e9utica, Silvia Jim\u00e9nez, comentando un caso pr\u00e1ctico. \"\/><\/a><figcaption class=\"wp-element-caption\">La farmac\u00e9utica, Silvia Jim\u00e9nez, comentando un caso pr\u00e1ctico. <\/figcaption><\/figure><\/div>\n\n\n\n<p>Cerr\u00f3 la jornada uno <strong>di\u00e1logo entre los profesionales en dermofarmacia. En Marta Alcalde, David Gardu\u00f1o<\/strong> y <strong>Jes\u00fas P\u00e9rez Fierro<\/strong>, se a\u00f1adi\u00f3 la farmac\u00e9utica comunitaria especialista en dermofarmacia, <strong>Gemma Rub\u00eds<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/12\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_7_ok-scaled.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/12\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_7_ok-1024x513.jpg\" alt=\"\" class=\"wp-image-65471\" title=\"Di\u00e1logo entre los profesionales Marta Alcalde, David Gardu\u00f1o, Gemma Rub\u00eds y Jes\u00fas P\u00e9rez Fierro.\"\/><\/a><figcaption class=\"wp-element-caption\">Di\u00e1logo entre los profesionales Marta Alcalde, David Gardu\u00f1o, Gemma Rub\u00eds y Jes\u00fas P\u00e9rez Fierro.<\/figcaption><\/figure>\n\n\n\n<p>En la mesa redonda se abordaron algunos de los<strong> mitos y creencias m\u00e1s extendidos hacia el c\u00e1ncer<\/strong>. <strong>Alcalde <\/strong>destac\u00f3 que \u201c<strong>el di\u00e1logo entre los diferentes profesionales debe servir para evaluar la evidencia cient\u00edfica que hay detr\u00e1s de cada uno de ellos<\/strong> y <strong>dar herramientas al farmac\u00e9utico para informar correctamente al paciente<\/strong>, evitando que por falta de conocimiento se generen falsas expectativas o bien se tomen actitudes que puedan ser peligrosas para el paciente\u201d.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Con la colaboraci\u00f3n de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-thumbnail\"><a href=\"https:\/\/www.laroche-posay.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/12\/LA-ROCHE-POSAY-logo-2022_transparent-150x39.png\" alt=\"\" class=\"wp-image-65453\"\/><\/a><\/figure>","protected":false},"excerpt":{"rendered":"<p>El pasado 23 de noviembre, el Colegio de Farmac\u00e9uticos de Barcelona (COFB) realiz\u00f3 una nueva formaci\u00f3n sobre &quot;La dermofarmacia y la oncolog\u00eda&quot;, con la colaboraci\u00f3n de La Roche-Posay. La jornada fue moderada por la vocal de Dermofarmacia y Productos Sanitarios del COFB, Marta Alcalde y dio a conocer [\u2026]<\/p>","protected":false},"author":1,"featured_media":67819,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[978,723,957,753,739,979,18,19,443,81,68,69,70,980,981,76,724,982,983],"class_list":["post-64909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica-comunitaria-al-pacient-amb-cancer","tag-cancer","tag-cancer-de-colon","tag-cancer-de-mama","tag-cancer-de-pell","tag-cancer-de-pulmo","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-dermocosmetica","tag-dermofarmacia","tag-farmacia","tag-farmacia-comunitaria","tag-formacio","tag-impacte-psicologic","tag-maquillatge-oncologic","tag-oficina-de-farmacia","tag-oncologia","tag-pacient-amb-cancer","tag-pacient-oncologic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T16:47:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-09T13:05:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria\",\"datePublished\":\"2022-12-12T16:47:55+00:00\",\"dateModified\":\"2023-10-09T13:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\"},\"wordCount\":1213,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\",\"keywords\":[\"atencio farmaceutica comunitaria al pacient amb cancer\",\"c\u00e0ncer\",\"c\u00e0ncer de c\u00f2lon\",\"c\u00e0ncer de mama\",\"c\u00e0ncer de pell\",\"c\u00e0ncer de pulm\u00f3\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"dermocosm\u00e8tica\",\"Dermofarm\u00e0cia\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"impacte psicol\u00f2gic\",\"maquillatge oncol\u00f2gic\",\"Oficina de farm\u00e0cia\",\"oncologia\",\"pacient amb c\u00e0ncer\",\"pacient oncol\u00f2gic\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\",\"name\":\"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\",\"datePublished\":\"2022-12-12T16:47:55+00:00\",\"dateModified\":\"2023-10-09T13:05:56+00:00\",\"description\":\"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/","og_locale":"es_ES","og_type":"article","og_title":"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.","og_url":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-12-12T16:47:55+00:00","article_modified_time":"2023-10-09T13:05:56+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria","datePublished":"2022-12-12T16:47:55+00:00","dateModified":"2023-10-09T13:05:56+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/"},"wordCount":1213,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg","keywords":["atencio farmaceutica comunitaria al pacient amb cancer","c\u00e0ncer","c\u00e0ncer de c\u00f2lon","c\u00e0ncer de mama","c\u00e0ncer de pell","c\u00e0ncer de pulm\u00f3","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","dermocosm\u00e8tica","Dermofarm\u00e0cia","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","impacte psicol\u00f2gic","maquillatge oncol\u00f2gic","Oficina de farm\u00e0cia","oncologia","pacient amb c\u00e0ncer","pacient oncol\u00f2gic"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/","url":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/","name":"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg","datePublished":"2022-12-12T16:47:55+00:00","dateModified":"2023-10-09T13:05:56+00:00","description":"El COFB va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche Posay.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/12\/12\/dermofarmacia-i-oncologia-actuacions-des-de-la-farmacia-comunitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Dermofarm\u00e0cia i oncologia. Actuacions des de la farm\u00e0cia comunit\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg",1024,512,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-300x150.jpg",300,150,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1-768x384.jpg",768,384,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg",1024,512,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg",1024,512,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg",1024,512,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_DERMOFARMACIA-I-ONCOLOGIA_23112022_9-1024x512-1.jpg",18,9,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 23 de novembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va realitzar una nova formaci\u00f3 sobre \u201cLa dermofarm\u00e0cia i l\u2019oncologia\u201d, amb la col\u00b7laboraci\u00f3 de La Roche-Posay. La jornada va ser moderada per la vocal de Dermofarm\u00e0cia i Productes Sanitaris del COFB, Marta Alcalde i va donar a con\u00e8ixer [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/64909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=64909"}],"version-history":[{"count":3,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/64909\/revisions"}],"predecessor-version":[{"id":68984,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/64909\/revisions\/68984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/67819"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=64909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=64909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=64909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}